Articles

Moving back and forth among the bedside, the laboratory, and the policy arena has given me a wide view of health. As a medical oncologist…

Explore how a biopreparedness map can strengthen special pathogens readiness, mass gathering planning, and frontline outbreak response…

Prevention of disease in patients of all ages is clearly the motivator for all primary care clinicians. Luckily, over time, we have had more…

My understanding of respiratory disease management has definitely increased substantially over time, and I really emphasize the importance…

Understand how poor-prognosis features may impact clinical decision-making in patients with unresectable hepatocellular carcinoma…

I came from the teaching that the patient always comes first, no matter what you’re doing. There was a deep respect for patients and…

While in medical school in Warsaw, I was involved in basic science research from my second year. I was very interested in biochemistry…

The treatment options for Clostridioides difficile are changing, with two FDA-approved microbiota products, discontinued therapies, and…

All three are highly advanced healthcare systems, but they are organized very differently. For example, in Switzerland…

Sodium hypochlorite (NaOCl), the active ingredient in household bleach, has long been a staple in medical history, yet its…

Aboriginal and Torres Strait Islander children face a disproportionate burden of dermatologic conditions, including preventable skin…

Morphea is a rare inflammatory disorder characterized by skin fibrosis, with linear morphea representing a distinct subtype that can lead…

Advanced AIDS is a diagnostic challenge. Profound immunosuppression (CD4 count

When I was in medical school, my brother had a rash. In retrospect, it was probably pityriasis rosea, but I don’t know that for a fact….

Christopher Tomassian. Founder/CEO, The Dermatology Collective, Glendora, California, USA.

Catch up on selected 2025-2026 conference data across AD, CHE, GPP, and PG, including symptom burden, long-term disease impact, and…

Within the heterogeneous group of diseases that constitute interstitial lung disease, biomarkers allowing for early disease identification…

Interview with David Fisher, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA…